Market Overview
Virology
Market is projected to achieve a value of USD 3.1 Billion in 2023, with a
linear behavior in the market growth it is forecasted to achieve a value of USD
4.97 Billion by 2033 with a CAGR of 5.62% during the forecast period 2024-2033.
The
global industry devoted to the investigation, identification, management, and
prophylaxis of viral illnesses is included in the virology market. It covers
studies, medications, medical diagnostics, and viral vaccinations. Emerging
viral dangers including HIV, influenza, and the COVID-19 pandemic have driven
research and development efforts and resulted in significant growth in the
market. The virology industry is divided into three major segments: vaccine development,
antiviral medications, and diagnostic technologies. Government spending and
public health programs also have a significant impact on how the market
behaves. Owing to the persistent difficulties caused by viral illnesses, the
virology industry is developing and growing.
The
World Health Organization (WHO) published a factsheet in January 2018 that
states that the combined effects of all influenza varieties generate epidemics
that result in between 3 and 5 million cases of severe disease each year, which
accounts for between 290 000 and 650 000 fatalities globally. While most
diagnostic tests are fast, PCR-based methods are also being utilized to
identify influenza.
Furthermore,
it is anticipated that developments in antiviral therapy—including improved
detection methods, drugs, and vaccines—will propel the market for virology
testing. There is a global search on to discover new vaccines and medications
to treat diseases resistant to viruses. For example, in Phase II trials,
AiCuris' investigational medication Pritelivir for the herpes simplex virus
(HSV) has shown to be highly successful when compared to the current
conventional antiviral therapies for genital herpes. Worldwide, a great deal of
research has been done on the treatment of highly contagious viral diseases
like Dengue, Malaria, and Ebola.
The
development of new technologies for the diagnosis and treatment of viral
diseases may facilitate market growth. For example, the technology of nanoscale
viral trap molecules, now undergoing investigation, may have applications in
the diagnosis of viral diseases. Using a novel adjustable technology, viruses
are selectively trapped and detected with a sensitivity 100 times higher than
existing methods. Another medication based on nanoparticles that is being
studied to treat viral diseases is called Double-stranded RNA Activated Caspase
Oligomerizer (DRACO).
The
market for virology has been significantly influenced by the COVID-19 outbreak.
It expedited the creation, testing, and manufacturing of vaccinations,
antiviral medications, and diagnostic tools. Rapid vaccine development and
distribution resulted from close collaboration between pharmaceutical firms and
research universities. The rise in government funding and public health
programs demonstrated the significance of virology in pandemic preparedness.
Patient care has changed as telemedicine and remote monitoring have become more
popular. On the other hand, resource competitiveness and supply chain
interruptions presented difficulties. The epidemic brought to light the vital
role that the virology market plays in maintaining global health, spurring
innovation, boosting funding, and raising public awareness of the significance
of virology research and solutions.
Market Scope
Report Attributes |
Description |
Market Size in 2023 |
USD 3.1 Billion |
Market Forecast in 2033 |
USD 4.97
Billion |
CAGR % 2024-2033 |
5.62% |
Base Year |
2023 |
Historic Data |
2016-2022 |
Forecast Period |
2024-2033 |
Report USP |
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
Segments Covered |
By Condition, By Treatment and By Region |
Regional Scope |
North America,
Europe, APAC, South America and Middle East and Africa |
Growth Drivers |
The focus on vaccine development to
prevent viral infections has been a significant driver of the virology
market. Efforts to combat diseases like influenza, human papillomavirus
(HPV), hepatitis, and emerging viruses contribute to research and development
activities in virology. The development of antiviral drugs for
the treatment of viral infections is a key driver of the virology
therapeutics market. Advances in drug discovery and the introduction of novel
antiviral agents contribute to the growth of this segment. Ongoing technological innovations, including
high-throughput sequencing, CRISPR-based technologies, and advanced imaging
techniques, enhance virology research capabilities. These technologies enable
researchers to better understand viruses and develop targeted interventions. |
Country Scope |
U.S.; Canada;
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Key Companies |
GlaxoSmithKline plc, Abbott
Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Trinity
Biotech, Johnson & Johnson, Roche, AstraZeneca AB, Novartis International
AG, Siemens and others. |
Market Dynamics
Market Drivers
The
prevalence of viral diseases
The
prevalence of viral infections is one of the key factors propelling the growth
of the virology market. Emerging infections including COVID-19, hepatitis,
HIV/AIDS, and influenza are driving the demand for innovative vaccines,
state-of-the-art therapies, and advanced diagnostics. Due of the necessity of
continual research and development to combat newly developing virus strains and
outbreaks, this ubiquity motivates investments in virology. The need to address
these health risks as soon as possible and the search for better treatments and
diagnostics, which is stimulating innovation and expanding virology research
and solutions, are driving the market's growth.
Advancements
in technology
Technological
developments are driving the virology industry by transforming research,
diagnosis, and therapy. Precision medicine techniques are made possible by
advances such as CRISPR gene editing, next-generation sequencing, and
high-throughput screening, which speed up the development of antiviral drugs.
These technologies improve the speed, accuracy, and sensitivity of virus
detection—all important during epidemics. Furthermore, sophisticated platforms
support vaccine development and enable quick reactions to newly discovered
viruses. The market is being driven towards more effective interventions and
better outcomes in the fight against viral illnesses by the continuous
evolution and use of state-of-the-art instruments, which also facilitate expert
collaboration and expedite virology research.
Market Restrains
Regulatory
Challenges
Regulatory
restrictions are a significant impediment to the virology market, impeding the
timely introduction of innovative products. Strict approval processes and
complex legal frameworks sometimes result in extended waiting times and costs
for medical and diagnostic clearances. Strict safety and efficacy standards,
albeit necessary, can result in lengthy delays in the release of novel
antiviral drugs and diagnostics. These barriers disproportionately affect
smaller companies with fewer resources, which limits their ability to bring
cutting-edge virology products to market rapidly and stifles innovation and expansion
in the sector at large.
Market- By Product Type Analysis
By Product Type, the Virology Market is Categories into Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons. The Diagnosing Test segment accounts for the largest share of around 42% in 2022.
This
is because there is a growing need for early viral infection diagnosis,
including for COVID-19, influenza, and HIV.
Market- By Application Analysis
By
Application, the Virology Market is Categories into Skin and Soft Tissue
Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract
Infections, Eye Infections, CNS Infections, Sexually Transmitted Diseases,
Perinatal Infections. The Respiratory Tract Infections segment accounts for the
largest share of around 36% in 2022.
The
respiratory tract infections industry has a big influence on the virology
business because respiratory viruses, like influenza, respiratory syncytial
virus (RSV), and coronaviruses, are so prevalent. The prevalence of these viral
illnesses poses a serious threat to world health, increasing the need for
diagnostic equipment, immunizations, and antiviral drugs.
Market- By End User Analysis
By
End User, the Virology Market is Categories into Hospitals, Clinics,
Laboratories. The Hospitals segment accounts for the largest share of around
35% in 2022.
Hospitals
play a major part in the delivery of healthcare, which accounts for their
significant market share in virology. They are essential hubs for the
diagnosis, treatment, and management of viral infections, making them major
consumers of virology-related products and services. Hospitals handle
epidemics, conduct regular testing, and provide critical care during pandemics.
They require a range of virology solutions, including equipment and immunizations,
antiviral drugs, and diagnostic testing.
Market-Regional Analysis
North
America dominate the Virology Market with the highest revenue generating market
with share of more than 43%. The region is renowned for its robust R&D
capabilities, sophisticated healthcare system, and significant investments in
virology research. Furthermore, North America has led the way in the fight
against viral infections due to a high demand for immunizations, antiviral
drugs, and diagnostic tests.
The
Asia-Pacific virology market is anticipated to grow rapidly due to several
favorable aspects. Its big and diverse population makes it particularly
susceptible to many viral infections, necessitating the ongoing development of
virology-related treatments. In addition, the growing economies in the region
are making significant investments in R&D and expanding their
infrastructure related to healthcare. Furthermore, Asia-Pacific has contributed
significantly to the development of virology expertise and innovation in response
to viral pandemics such as SARS and COVID-19.
Competitive Analysis
The
Virology Market is dominated by a few large companies, such as GlaxoSmithKline
plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc.,
Trinity Biotech, Johnson & Johnson, Roche, AstraZeneca AB, Novartis
International AG, Siemens and others.
There
are some of the key trends that are shaping the competitive landscape of the Virology
Market.
In
May 2022, The Q-POC SARS-CoV-2, Flu A/B & RSV Assay is the newest respiratory
panel test offered by QuantuMDx Group Limited. Operating on the
multiplex-capable Q-POC platform, this novel assay is designed to function.
This development makes it possible for users to perform quick point-of-care
testing in a variety of clinical and non-clinical contexts.
Research Report Following Segments:
By Product Type
·
Diagnosing Test
·
Viral Infection
Controlling Methods
·
Antiviral Chemotherapy
·
Interferons
By Application
·
Skin and Soft Tissue
Infections
·
Respiratory Tract
Infections GI Tract Infections
·
Urinary Tract Infections
·
Eye Infections
·
CNS Infections
·
Sexually Transmitted
Diseases
·
Perinatal Infections
By End User
·
Hospitals
·
Clinics
Laboratories
1.
Global Virology Market
Introduction and Market Overview
1.1. Objectives
of the Study
1.2. Global
Virology Market Scope and Market Estimation
1.2.1. Global
Virology Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market
forecast (2023 - 2033)
1.2.2. Global
Virology Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2033
1.3. Market
Segmentation
1.3.1. Component
of Global Virology Market
1.3.2. Technology
of Global Virology Market
1.3.3. End-user
of Global Virology Market
1.3.4. Region
of Global Virology Market
2.
Executive
Summary
2.1. Global
Virology Market Industry Trends
under COVID-19 Outbreak
2.1.1. Global
COVID-19 Status Overview
2.1.2. Influence
of COVID-19 Outbreak on Global Virology
Market Industry Development
2.2. Market
Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact
Analysis of Drivers and Restraints
2.3. Pricing
Trends Analysis & Average Selling Prices (ASPs)
2.4. Key
Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.
2.5. Porter’s
Five Forces Analysis
2.5.1. Bargaining
Power of Suppliers
2.5.2. Bargaining
Power of Buyers
2.5.3. Threat
of Substitutes
2.5.4. Threat
of New Entrants
2.5.5. Competitive
Rivalry
2.6. Value
Chain / Ecosystem Analysis
2.7. Russia-Ukraine
War Impacts Analysis
2.8. Economic
Downturn Analysis
2.9. Market
Investment Opportunity Analysis (Top Investment Pockets), By Segments & By
Region
3.
Global
Virology Market Estimates & Historical Trend Analysis (2019 -
2022)
4.
Global
Virology Market Estimates & Forecast Trend Analysis, by PRODUCT TYPE
4.1. Global
Virology Market Revenue (US$ Mn) Estimates and Forecasts, by PRODUCT TYPE, 2019
to 2033
4.1.1. Diagnosing
Test
4.1.2. Viral
Infection Controlling Methods
4.1.3. Antiviral
Chemotherapy
4.1.4.
Interferons
5. Global Virology Market Estimates
& Forecast Trend Analysis, by
Application
5.1. Global
Virology Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019
to 2033
5.1.1. Skin
and Soft Tissue Infections
5.1.2. Respiratory
Tract Infections GI Tract Infections
5.1.3. Urinary
Tract Infections
5.1.4. Eye
Infections
5.1.5. CNS
Infections
5.1.6. Sexually
Transmitted Diseases
5.1.7. Perinatal
Infections
6. Global Virology Market Estimates
& Forecast Trend Analysis, by
End-user
6.1. Global
Virology Market Revenue (US$ Mn) Estimates and Forecasts, by End-user,
2019 to 2033
6.1.1. Hospitals
6.1.2. Clinics
6.1.3. Laboratories
7.
Global
Virology Market Estimates & Forecast Trend Analysis, by Region
7.1. Global
Virology Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2033
7.1.1. North
America
7.1.2. Europe
7.1.3. Asia
Pacific
7.1.4. Middle
East & Africa
7.1.5. South
America
8.
North America Virology Market: Estimates & Forecast Trend Analysis
8.1.
North America Virology
Market Assessments & Key Findings
8.1.1. North
America Virology Market Introduction
8.1.2. North
America Virology Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
8.1.2.1.
By PRODUCT TYPE
8.1.2.2.
By Application
8.1.2.3.
By End-user
8.1.2.4. By
Country
8.1.2.4.1. The
U.S.
8.1.2.4.2. Canada
8.1.2.4.3. Mexico
9.
Europe Virology Market: Estimates & Forecast Trend Analysis
9.1. Europe
Virology Market Assessments & Key Findings
9.1.1. Europe
Virology Market Introduction
9.1.2. Europe
Virology Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
9.1.2.1.
By PRODUCT TYPE
9.1.2.2.
By Application
9.1.2.3.
By End-user
9.1.2.4. By
Country
9.1.2.4.1. Germany
9.1.2.4.2. U.K.
9.1.2.4.3. France
9.1.2.4.4. Italy
9.1.2.4.5. Spain
9.1.2.4.6. Russia
9.1.2.4.7. Rest
of Europe
10.
Asia Pacific Virology Market: Estimates & Forecast Trend Analysis
10.1. Asia
Pacific Market Assessments & Key Findings
10.1.1. Asia
Pacific Virology Market Introduction
10.1.2. Asia
Pacific Virology Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
10.1.2.1.
By PRODUCT TYPE
10.1.2.2.
By Application
10.1.2.3.
By End-user
10.1.2.4. By
Country
10.1.2.4.1.
China
10.1.2.4.2.
Japan
10.1.2.4.3.
India
10.1.2.4.4.
Australia
10.1.2.4.5.
South Korea
10.1.2.4.6.
ASEAN
10.1.2.4.7.
Rest of Asia Pacific
11.
Middle East & Africa Virology Market: Estimates & Forecast Trend Analysis
11.1. Middle
East & Africa Market Assessments & Key Findings
11.1.1. Middle East & Africa Virology
Market Introduction
11.1.2. Middle East & Africa Virology
Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
11.1.2.1.
By PRODUCT TYPE
11.1.2.2.
By Application
11.1.2.3.
By End-user
11.1.2.4. By
Country
11.1.2.4.1.
U.A.E.
11.1.2.4.2.
Saudi Arabia
11.1.2.4.3.
Egypt
11.1.2.4.4.
South Africa
11.1.2.4.5.
Rest of Middle East &
Africa
12.
South America Virology Market: Estimates & Forecast Trend Analysis
12.1. South
America Market Assessments & Key Findings
12.1.1. South
America Virology Market Introduction
12.1.2. South
America Virology Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
12.1.2.1.
By PRODUCT TYPE
12.1.2.2.
By Application
12.1.2.3.
By End-user
12.1.2.4. By
Country
12.1.2.4.1.
Brazil
12.1.2.4.2.
Argentina
12.1.2.4.3.
Colombia
12.1.2.4.4.
Rest of South America
13. Competition
Landscape
13.1. Global
Virology Market Competition Matrix & Benchmarking, by Leading Players /
Innovators / Emerging Players / New Entrants
13.2. Global
Virology Market Competition White Space Analysis, By End-user
13.3. Global
Virology Market Competition Heat Map Analysis, By End-user
13.4. Global
Virology Market Concentration & Company Market Shares (%) Analysis, 2022
14. Company
Profiles
14.1.
GlaxoSmithKline
plc.
14.1.1. Company
Overview & Key Stats
14.1.2. Financial
Performance & KPIs
14.1.3. Product
Portfolio
14.1.4. Business
Strategy & Recent Developments
* Similar details would be provided for all the
players mentioned below
14.2.
Abbott
Laboratories
14.3.
Boehringer
Ingelheim Corporation
14.4.
Merck
and Co. Inc.
14.5.
Trinity
Biotech
14.6.
Johnson
& Johnson
14.7.
Roche
14.8.
AstraZeneca
AB
14.9.
Novartis
International AG
14.10. Siemens
14.11. others
15.
Research
Methodology
15.1. External
Transportations / Databases
15.2. Internal
Proprietary Database
15.3. Primary
Research
15.4. Secondary
Research
15.5. Assumptions
15.6. Limitations
15.7. Report
FAQs
16.
Research
Findings & Conclusion
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Virology Market was valued at USD 2.4 Billion in 2022.
Virology Market size will increase at approximate CAGR of 5.62% during the forecasted period.
Major companies operating within the Virology Market are GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Trinity Biotech, Johnson & Johnson, Roche, AstraZeneca AB, Novartis International AG, Siemens and others.
North America dominates the market with an active share of 43%.
Only Three Thousand Four Hundred Ninety Nine US dollar
Only Four Thousand Four Hundred Ninety Nine US dollar
Only Five Thousand Four Hundred Ninety Nine US dollar